Literature DB >> 7962638

Pregnancy after treatment with hydroxyurea in a patient with primary thrombocythaemia and a history of recurrent abortion.

K I Cinkotai1, P Wood, P Donnai, J Kendra.   

Abstract

A 28 year old patient with primary thrombocythaemia, who had had two stillbirths in the third trimester, is reported. She was successfully treated with hydroxyurea and delivered a healthy 6lb boy by elective caesarean section. The ease with which this treatment can be given, its high level of tolerance among patients, and its low cost are likely to increase its use as a safe and effective treatment in pregnant patients with primary thrombocythaemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962638      PMCID: PMC502158          DOI: 10.1136/jcp.47.8.769

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Type II interferon may be a potential hazardous therapeutic agent during pregnancy.

Authors:  S Vassiliadis; I Athanassakis
Journal:  Br J Haematol       Date:  1992-12       Impact factor: 6.998

2.  Pregnancy during myelosuppressive treatment for chronic myelogenous leukemia.

Authors:  A Delmer; B Rio; F Bauduer; F Ajchenbaum; J P Marie; R Zittoun
Journal:  Br J Haematol       Date:  1992-12       Impact factor: 6.998

3.  Hydroxyurea and pregnancy.

Authors:  G Tertian; G Tchernia; E Papiernik; E Elefant
Journal:  Am J Obstet Gynecol       Date:  1992-06       Impact factor: 8.661

4.  Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia.

Authors:  M R Baer; H Ozer; K A Foon
Journal:  Br J Haematol       Date:  1992-06       Impact factor: 6.998

5.  Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.

Authors:  S Murphy; H Iland; D Rosenthal; J Laszlo
Journal:  Semin Hematol       Date:  1986-07       Impact factor: 3.851

6.  Busulfan in early pregnancy.

Authors:  D W Williams
Journal:  Obstet Gynecol       Date:  1966-05       Impact factor: 7.661

Review 7.  Primary thrombocythaemia in pregnancy.

Authors:  J Beard; P Hillmen; C C Anderson; S M Lewis; T C Pearson
Journal:  Br J Haematol       Date:  1991-03       Impact factor: 6.998

8.  Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy.

Authors:  N Jackson; A Shukri; K Ali
Journal:  Br J Haematol       Date:  1993-09       Impact factor: 6.998

9.  Primary thrombocythemia in pregnancy: a report of two cases.

Authors:  B Mercer; J Drouin; E Jolly; G d'Anjou
Journal:  Am J Obstet Gynecol       Date:  1988-07       Impact factor: 8.661

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.